Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 3016 results.
User Information
Export Records
  1. 1.   Neovascular pruning by IDO1 inhibitors can potentiate immunogenic cytotoxicity of ischemia-targeted agents to synergistically enhance anti-PD-1 responsiveness
  2. Shen, Shih-Chun; Dey, Souvik; DuHadaway, James B; Sutanto-Ward, Erika; Hampton, Maurice T; Kozlov,Serguei; Prendergast, George C; Muller, Alexander J
  3. Journal for Immunotherapy of Cancer. 2025, May 30; 13(5):
  1. 2.   Phase 1 studies of the indenoisoquinolines LMP776 and LMP744 in patients with solid tumors and lymphomas
  2. O'Sullivan Coyne, Geraldine; Kummar, Shivaani; Rubinstein, Larry V; Wilsker,Deborah; Moore, Nancy; Hogu, Murielle; Piekarz, Richard; Covey, Joe; Beumer, Jan H; Ferry-Galow,Katherine; Villaruz, Liza C; Hollingshead,Melinda; Holleran, Julianne L; Deppas, Joshua J; Pommier, Yves; Ko, Brian; Johnson, Barry C; Parchhment, Ralph E; Ivy, Percy; Doroshow, James H; Chen, Alice P
  3. Cancer Chemotherapy and Pharmacology. 2025, May 29; 95(1): 58.
  1. 3.   Clinicopathologic Features, Management, and Outcomes Of Pediatric CRTC1::TRIM11 and MED15::ATF1 Tumors With Spitzoid Morphology: A Case Series
  2. Sargen, Michael R; Fitzhugh, Madeline H; Ko, Jennifer S; Close, Allison G; Horton, Sara C; Malik, Faizan; Furtado, Larissa V; Bahrami, Armita; Seynnaeve, Brittani K N; Pappo, Alberto S; Liu, Vincent; Cheung, Kevin; Pack, Svetlana D; Xi, Liqiang; Raffeld, Mark; Lee, Ina; Gagan, Jeffrey; Aldape, Kenneth; Barr, Frederic G; Hewitt, Stephen M; Ferrone, Christina K; Hayden, Anna; Hatton, Jessica N; Goldstein, Alisa M; Pfeiffer, Ruth M; Widemann, Brigitte; Malone, Mary Frances Wedekind; Gross, Andrea M; Kaplan, Rosandra; Yohe,Marielle; Berrebi, Kristen G
  3. Pediatric Blood & Cancer. 2025, May 19; e31814.
  1. 4.   m276-SL-PBD eradicates tumors and instigates long-lasting tumor-free survival in Merkel cell carcinoma preclinical models
  2. Kunika, Mikaela D; Kannan, Aarthi; Velasco, Graham J; Feng,Yang; Seaman,Steven; Das, Bhaba K; Pham, Dillon; Lambrecht, Nils; Zhao, Haibo; St Croix,Bradley; Gao, Ling
  3. iScience. 2025, May 16; 28(5): 112436.
  1. 5.   Exploiting the therapeutic vulnerability of IDH-mutant gliomas with zotiraciclib
  2. Pang, Ying; Li, Qi; Sergi, Zach; Yu, Guangyang; Kim, Olga; Lu, Peng; Chan, Marina; Sang, Xueyu; Wang, Herui; Ranjan, Alice; Robey, Robert W; Soheilian, Ferri; Tran,Bao; Núñez, Felipe J; Zhang, Meili; Song, Hua; Zhang, Wei; Davis, Dionne; Gilbert, Mark R; Gottesman, Michael M; Liu, Zhenggang; Thomas, Craig J; Castro, Maria G; Gujral, Taranjit S; Wu, Jing
  3. iScience. 2025, Apr 18; 28(4): 112283.
  1. 6.   CDK2 Inhibition Produces a Persistent Population of Polyploid Cancer Cells
  2. Tyutyunyk-Massey, Liliya; Chen,Zibo; Liu,Xiuxia; Kawakami, Masanori; Harned,Adam; Ng, Yeap; Harned,Adam; Okpechi,Samuel; Ogunlade,Blessing; Alfaro Mora,Yair; Weigert, Roberto; Narayan,Kedar; Liu,Xi; Dmitrovsky,Ethan
  3. JCI Insight. 2025, Apr 15;
  1. 7.   Developmental onset of planarian whole-body regeneration depends on axis reset
  2. Booth, Clare L T; Stevens, Brian C; Stubbert, Clover A; Kallgren,Neil; Deihl,Ennis; Davies,Erin
  3. Current Biology : CB. 2025, Apr 11;
  1. 8.   Ror gamma t-positive dendritic cells are required for the induction of peripheral regulatory T cells in response to oral antigens
  2. Rodrigues, Patrick Fernandes; Wu, Shitong; Trsan, Tihana; Panda, Santosh K; Fachi, José Luís; Liu, Yizhou; Du, Siling; de Oliveira, Sarah; Antonova, Alina Ulezko; Khantakova, Darya; Sudan, Raki; Desai, Pritesh; Diamond, Michael S; Gilfillan, Susan; Anderson,Stephen; Cella, Marina; Colonna, Marco
  3. Cell. 2025, Apr 01;
  1. 9.   Discovery of potent and selective PROTACs for the protein kinase LZK for the treatment of head and neck cancer
  2. Katerji,Meghri; Bergman, Knickole L; Lindberg, Eric; Rubin,Maxine; Funk, Amy L; Woodroofe, Carolyn C; Nyswaner, Katherine; Karpinska, Kamila; Serwa, Remigiusz; Marusiak, Anna; Swenson, Rolf E; Brognard,John
  3. The Journal of Biological Chemistry. 2025, Mar 27; 108452.
  1. 10.   PLS-a-GalCer: a novel targeted glycolipid therapy for solid tumors
  2. Burks, Julian; Tiwary, Shweta; Stevens, David M; Skoczen,Sarah; Kularatne,Ruvanthi Nilanga; Stern,Stephan; Berzofsky, Jay A
  3. Journal for Immunotherapy of Cancer. 2025, Mar 22; 13(3):
  1. 11.   PRGN-2009 and bintrafusp alfa for patients with advanced or metastatic human papillomavirus-associated cancer
  2. Floudas, Charalampos S; Goswami, Meghali; Donahue, Renee N; Strauss, Julius; Pastor, Danielle M; Redman, Jason M; Brownell, Isaac; Turkbey, Evrim B; Steinberg, Seth M; Cordes, Lisa M; Marté, Jennifer L; Khan, Maheen H; McMahon, Sheri; Lamping, Elizabeth; Manu,Michell; Manukyan,Manuk; Brough, Douglas E; Lankford, Amy; Jochems, Caroline; Schlom, Jeffrey; Gulley, James L
  3. Cancer Immunology, Immunotherapy : CII. 2025, Mar 21; 74(5): 155.
  1. 12.   Inhibition of Ribosome Biogenesis in vivo Causes p53-Dependent Death and p53-Independent Dysfunction
  2. Cho, Charles J; Nguyen, Thanh; Rougeau, Amala K; Huang, Yang-Zhe; To, Sarah; Lin, Xiaobo; Thalalla Gamage,Supuni; Meier,Jordan; Mills, Jason C
  3. Cellular and Molecular Gastroenterology and Hepatology. 2025, Mar 11; 101496.
  1. 13.   Virologic effects of broadly neutralizing antibodies VRC01LS and VRC07-523LS on chronic HIV-1 infection
  2. Happe, Myra; Lynch, Rebecca M; Fichtenbaum, Carl J; Heath, Sonya L; Koletar, Susan L; Landovitz, Raphael J; Presti, Rachel M; Santana-Bagur, Jorge L; Tressler, Randall L; Holman, LaSonji A; Novik, Laura; Roa, Jhoanna C; Rothwell, Ro Shauna; Strom, Larisa; Wang,Jing; Hu, Zonghui; Conan-Cibotti, Michelle; Bhatnagar, Anjali M; Dwyer, Bridget; Ko, Sung Hee; Belinky, Frida; Namboodiri, Aryan M; Pandey, Janardan P; Carroll, Robin; Basappa, Manjula; Serebryannyy, Leonid; Narpala, Sandeep R; Lin, Bob C; McDermott, Adrian B; Boritz, Eli A; Capparelli, Edmund V; Coates, Emily E; Koup, Richard A; Ledgerwood, Julie E; Mascola, John R; Chen, Grace L; Tebas, Pablo
  3. JCI Insight. 2025, Feb 24; 10(4):
  1. 14.   Histidine Tag-Specific PEGylation Improves the Circulating Half-Life of TIMP2
  2. Toor, Jack; Grabowska, Wiktoria R; Johnson, Adam L; Jones,Jane; Stetler-Stevenson, William G; Khalili, Hanieh; Peeney, David
  3. ACS Applied Bio Materials. 2025, Feb 21;
  1. 15.   Olaparib in treatment-refractory isocitrate dehydrogenase 1 (IDH1)- and IDH2-mutant cholangiocarcinoma: Safety and antitumor activity from the phase 2 National Cancer Institute 10129 trial
  2. Cecchini, Michael; Pilat, Mary Jo; Uboha, Nataliya; Azad, Nilofer S; Cho, May; Davis, Elizabeth J; Ahnert, Jordi Rodon; Tinoco, Gabriel; Shapiro, Geoffrey I; Khagi, Simon; Powers, Benjamin; Spencer, Kristen; Groisberg, Roman; Drappatz, Jan; Chen, Li; Das,Bishu; Bao, Xun; Li, Jing; Narayan, Azeet; Vu, Dennis; Patel, Abhijit; Niger, Monica; Doroshow, Deborah; Durecki, Diane; Boerner, Scott A; Bindra, Ranjit; Ivy, Percy; Shyr, Derek; Shyr, Yu; LoRusso, Patricia M
  3. Cancer. 2025, Feb 15; 131(4): e35755.
  1. 16.   Structural basis for complement receptor engagement and virus neutralization through Epstein-Barr virus gp350
  2. Joyce, M Gordon; Bu, Wei; Chen, Wei-Hung; Gillespie, Rebecca A; Andrews, Sarah F; Wheatley, Adam K; Tsybovsky,Yaroslav; Jensen, Jaime L; Stephens,Tyler; Prabhakaran, Madhu; Fisher, Brian E; Narpala, Sandeep R; Bagchi, Meghna; McDermott, Adrian B; Nabel, Gary J; Kwong, Peter D; Mascola, John R; Cohen, Jeffrey I; Kanekiyo, Masaru
  3. Immunity. 2025, Feb 11; 58(2): 295-308.e5. .
  1. 17.   Modulation of the Substrate Preference of a MYST Acetyltransferase by a Scaffold Protein
  2. Sengupta, Raghuvir N; Brodsky, Oleg; Bingham, Patrick; Diehl, Wade C; Ferre, RoseAnn; Greasley, Samantha E; Johnson, Eric; Kraus, Michelle; Lieberman, Whitney; Meier,Jordan; Paul, Thomas A; Maegley, Karen A
  3. The Journal of Biological Chemistry. 2025, Feb 03; 108262.
  1. 18.   Longitudinal single-cell profiles of lung regeneration after viral infection reveal persistent injury-associated cell states
  2. Niethamer, Terren K; Planer, Joseph D; Morley, Michael P; Babu, Apoorva; Zhao, Gan; Basil, Maria C; Cantu, Edward; Frank, David B; Diamond, Joshua M; Nottingham, Ana N; Li, Shanru; Sharma,Arnav; Hallquist, Hannah; Levin, Lillian I; Zhou, Su; Vaughan, Andrew E; Morrisey, Edward E
  3. Cell Stem Cell. 2025, Jan 13;
  1. 19.   Aberrant Wnt/ß-catenin signaling in the mesenchymal stem cells of LZTFL1-depleted mice leads to increased adipogenesis, with implications for obesity
  2. Badralmaa,Yunden; Natarajan,Ven
  3. The Journal of Biological Chemistry. 2024, Dec 09; 108057.
  1. 20.   Affinity Tag-Free Purification of SARS-CoV-2 N Protein and Its Crystal Structure in Complex with ssDNA
  2. Maiti,Atanu; Matsuo,Hiroshi
  3. Biomolecules. 2024, Nov 30; 14(12):
  1. 21.   Adoptive transfer of membrane-restricted IL-12-TCR T cells promotes antigen spreading and elimination of antigen-negative tumor variants
  2. Zhang, Ling; Norberg, Scott M; Karimipour, Farrah; Davies, John S; Kuznetsov, Alex; Lassoued, Wiem; Burnett, Daniel; Homan,Philip; Cam, Margaret; Sinkoe, Andrew; Xue, Ping; Gulley, James L; Hinrichs, Christian S
  3. Journal for Immunotherapy of Cancer. 2024, Nov 18; 12(11):
  1. 22.   Design, Synthesis and Biological Evaluation of 2-Phenyl Indole Analogues of OXi8006 as Colchicine Site Inhibitors of Tubulin Polymerization and Vascular Disrupting Agents
  2. Vairin, Rebecca; Tamminga, Caleb; Shi, Zhe; Borchardt, Christian; Jambulapati, Jayaram; Bai, Ruoli; Wanniarachchi, Hashini; Bueno, Lorena; Hamel,Ernest; Mason, Ralph P; Trawick, Mary Lynn; Pinney, Kevin G
  3. Bioorganic & Medicinal Chemistry. 2024, Nov 07; 118: 117981.
  1. 23.   Leveraging long-acting IL-15 agonists for intratumoral delivery and enhanced antimetastatic activity
  2. Hangasky, John A; Fernández, Rocío Del Valle; Stellas,Dimitris; Hails, Guillermo; Karaliota,Sevasti; Ashley, Gary W; Felber,Barbara; Pavlakis,George; Santi, Daniel V
  3. Frontiers in Immunology. 2024, Nov 4; 15: 1458145.
  1. 24.   Perplexing paradoxical reactions: navigating the complexity of protracted tuberculosis meningitis-a case report
  2. Gooding,Megan; Hammoud, Dima A; Epling, Brian; Rocco, Joseph; Laidlaw, Elizabeth; Kuriakose,Safia; Chaturvedi, Mansi; Galindo, Frances; Ma, Stella V; Mystakelis, Harry; Poole, April; Russo, Kelly; Shah, Maunank; Malone, Joseph L; Rupert,Adam; Sereti, Irini; Manion, Maura
  3. Frontiers in Immunology. 2024, Oct 31; 15: 1441945.
  1. 25.   Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial
  2. Davar, Diwakar; Morrison, Robert M; Dzutsev, Amiran K; Karunamurthy, Arivarasan; Chauvin, Joe-Marc; Amatore, Florent; Deutsch, Julie S; Das Neves, Rodrigo X; Rodrigues,Richard; McCulloch, John A; Wang, Hong; Hartman, Douglas J; Badger, Jonathan H; Fernandes, Miriam R; Bai, Yulong; Sun, Jie; Cole, Alicia M; Aggarwal, Poonam; Fang, Jennifer R; Deitrick, Christopher; Bao, Riyue; Duvvuri, Umamaheswar; Sridharan, Shaum S; Kim, Seungwon W; A Choudry, Haroon; Holtzman, Matthew P; Pingpank, James F; O'Toole, James Patrick; DeBlasio, Richelle; Jin, Yang; Ding, Quanquan; Gao, Wentao; Groetsch, Christopher; Pagliano, Ornella; Rose, Amy; Urban, Corey; Singh, Jagjit; Divarkar, Prajan; Mauro, David; Bobilev, Dmitri; Wooldridge, James; Krieg, Arthur M; Fury, Matthew G; Whiteaker, Jeffrey R; Zhao, Lei; Paulovich, Amanda G; Najjar, Yana G; Luke, Jason J; Kirkwood, John M; Taube, Janis M; Park, Hyun Jung; Trinchieri, Giorgio; Zarour, Hassane M
  3. Cancer Cell. 2024, Oct 30;
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel